Natural Killer Cells in Asthma by Khalil Karimi & Paul Forsythe
REVIEW ARTICLE
published: 21 June 2013
doi: 10.3389/fimmu.2013.00159
Natural killer cells in asthma
Khalil Karimi 1,2* and Paul Forsythe2,3
1 Institut für Experimentelle Immunologie und Hepatologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
2 Department of Medicine, Brain-Body Institute, McMaster University, Hamilton, ON, Canada
3 Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada
Edited by:
Eric Vivier, Centre d’Immunologie de
Marseille-Luminy, France
Reviewed by:
Eric Vivier, Centre d’Immunologie de
Marseille-Luminy, France
Jacques Zimmer, Centre de
Recherche Public de la Santé,
Luxembourg
Bart Lambrecht, VIB University of
Gent, Belgium
*Correspondence:
Khalil Karimi , Institut für
Experimentelle Immunologie und
Hepatologie, Universitätsklinikum
Hamburg-Eppendorf, Campus
Forschung N27, Martinistr. 52, 20246
Hamburg, Germany
e-mail: k.karimi@uke.de
The worldwide prevalence, morbidity, and mortality of asthma have dramatically increased
over the last few decades and there is a clear need to identify new effective therapeutic
and prophylactic strategies. Despite high numbers of NK cells in the lung and their ability
to generate a variety of immunomodulatory mediators, the potential of NK cells as ther-
apeutic targets in allergic airway disease has been largely overlooked. The fact that IgE,
acting through FcγRIII, can activate NK cells resulting in cytokine/chemokine production
implies that NK cells may contribute to IgE-mediated allergic responses. Indeed, current
evidence suggests that NK cells can promote allergic airway responses during sensitization
and ongoing inflammation. In animal models, increased NK cells are observed in the lung
following antigen challenge and depletion of the cells before immunization inhibits allergic
airway inflammation. Moreover, in asthmatics, NK cell phenotype is altered and may con-
tribute to the promotion of a pro-inflammatory Th2-type environment. Conversely, driving
NK cells toward an IFN-γ-secreting phenotype can reduce features of the allergic airway
response in animal models. However, we have limited knowledge of the signals that drive
the development of distinct subsets and functional phenotypes of NK cells in the lung and
thus the role and therapeutic potential of NK cells in the allergic airway remains unclear.
Here we review the potentially diverse role of NK cells in allergic airway disease, identify
gaps in current knowledge, and discuss the potential of modulating NK cell function as a
treatment strategy in asthma.
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ASTHMA
Asthma is a chronic airway disease, whose symptoms include
wheezing, chest tightness, breathlessness, and coughing with vari-
able and often reversible airway obstruction together with airway
hyper-responsiveness (Holgate, 2011b).
Asthma generally develops in childhood and is associated with
sensitization of the airways to aeroallergens such as house dust
mites, cockroaches, animal dander, fungi, and pollens (Holgate,
2011a). In most cases, this occurs through the selective expan-
sion of T lymphocytes that secrete an array of largely Th2-type
cytokines. These cytokines drive the characteristic events of air-
way inflammation central to disease pathophysiology in allergic
asthma. Such events include: promotion of Th2 cell survival, B
cell isotype switching to IgE synthesis, mast-cell differentiation
and maturation, basophil recruitment, and eosinophil maturation
and survival (Corrigan et al., 1988; Humbles et al., 2004; Kay, 2005,
2006; Holgate, 2011b). Variable airflow obstruction and associ-
ated airway hyper-responsiveness are driven both by the release
of potent inflammatory mediators and through remodeling of
the airway wall. As the severity of disease increases, the airway
becomes more susceptible to environmental insults such as biolog-
ically active allergens, viruses, and air pollutants. Damage caused
by these insults is further enhanced by an altered repair response
leading to mucus cell metaplasia, smooth muscle proliferation,
increased innervation, and fibrosis (Tang et al., 2006; Folli et al.,
2008; Bara et al., 2010).
While adaptive immune responses have been well studied in
regard to asthma, in recent years, there has been increased aware-
ness and interest in the role of innate immune responses in
regulating susceptibility to, and severity of, asthma. In particular,
the role of innate responses to respiratory viral infections in dri-
ving allergic asthma and the potential for certain bacterial signals
to protect against the disease have come under intense investiga-
tion (reviewed in von Mutius and Vercelli, 2010; Holgate, 2012;
Holtzman, 2012).
NATURAL KILLER CELLS AND LUNG INFLAMMATION
NK cells are the key to the natural defenses of the body (Cooper
et al., 2009) and have been detected in virtually all species from
invertebrates to mammals. As components of the innate immune
response, NK cells do not require previous sensitization to insti-
gate their action (Kiessling et al., 1975; Forsythe et al., 2007). NK
cells mediate cellular toxicity (Leavy, 2012) and release chemokines
and cytokines involved in combating tumors (Karimi et al., 2008),
viral infections (Berahovich et al., 2006), parasites (Evans and Jaso-
Friedmann, 1993), and bacteria (Ashkar et al., 2009). Uterine NK
cells also release mediators, such as vascular endothelial growth
factor (VEGF) and placental growth factor (PGF), which play a
major role in the vascularization of implanting embryos during
pregnancy (Ashkar et al., 2000; Kalkunte et al., 2008).
The function of NK cells is regulated by a large repertoire of
inhibitory and activating receptors (Raulet et al., 2001; Lanier,
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2008). One particular activating receptor, NKp46, found on a rare
T-cell population (Narni-Mancinelli et al., 2011) and a subset of
gut innate lymphoid cells (ILCs) (Tomasello et al., 2012), is con-
sidered a unifying surface marker of NK cells across all species
(Walzer et al., 2007). However, in humans, NK cells have tradi-
tionally been defined as cells that lack the T-cell receptor CD3 but
express CD56 with or without CD16 (Milush et al., 2009). In mice,
NK cells are defined as CD3− NK1.1+ or DX5+ cells (Wingett and
Nielson, 2003).
NK cell-activating receptors include the natural cytotoxicity
receptors (NCRs), such as NKp46 and NKp44, the Fc receptor
CD16, and NKG2D. The ligands for NK cell-activating receptors
include both host and pathogen glycoproteins. Thus, NKG2D rec-
ognizes the stress-induced ligand MHC class I polypeptide-related
sequence A (MICA), while NKp46 and NKp44 can directly bind
influenza hemagglutinin, a response that is key to the role of NK
cells in protecting against infection by the virus (Arnon et al., 2001;
Mandelboim et al., 2001).
It is also important that NK cells remain tolerant of healthy
tissue, and as such they express receptors that can prevent cell acti-
vation. Inhibitory receptors, such as killer immunoglobulin-like
receptors (KIRs) and the NKG2A:CD94 dimer, generally recog-
nize classical and non-classical class I major histocompatibility
complex (MHC) molecules (Colonna et al., 1993; Valiante et al.,
1997; Boyington et al., 2000; Culley, 2009).
NK cells develop in the bone marrow and migrate to the blood
as circulating cells, or become resident cells in tissues such as the
liver, spleen, lymph nodes, uterus, and lungs. NK cell recruitment
to tissues is under the control of the chemokine receptors CCR2,
CCR5, CX3CR1, and CXCR3 (Di Santo, 2006) and migration can
occur in response to infectious (Salazar-Mather et al., 1998; Zeng
et al., 2003) or allergic inflammation (von Bubnoff et al., 2010).
The relatively high frequency as well as total number of NK cells in
the lung compared to other organs (Gregoire et al., 2007; Culley,
2009) supports a prominent role for these cells in the immunology
of the airways.
Innate immune cells in the lung have the job of defending the
organ’s vital function against the constant barrage of exposures
to environmental antigens, commensal organisms, and potential
pathogens. The role of NK cells in protecting against respira-
tory infection by fungi, bacteria, and viruses [including influenza
and respiratory syncytial virus (RSV)] has been well described in
mouse models (reviewed in Culley, 2009).
NK cells control viral infections by multiple mechanisms
including up-regulating the expression of NKG2D (Lodoen et al.,
2003), IFN signaling (Trinchieri et al., 1978), and cytokine and
chemokine secretion (Vujanovic et al., 2010), which bring about
cytolysis of the virally infected cells (Malhotra and Shanker, 2011).
Following influenza infection, NK cells are increased in the lungs
(Gazit et al., 2006; Nakamura et al., 2010), activate CD8+ T-cell
effector functions (Qian et al., 1998), and modulate pulmonary
inflammation (Abdul-Careem et al., 2012). NK cells are responsi-
ble for lung injury during respiratory virus infection either alone
(Yasui et al., 2004; Li et al., 2012) or in combination with IL-18
(Harker et al., 2010).
The contribution of NK cells to the defense against viral infec-
tion may also afford the cells a pivotal role in regulating the
pathogenesis of asthma. Infection with rhinoviruses is not only
the major cause of asthma exacerbations, there is also extensive
evidence of a relationship between the development of asthma and
severe lower respiratory infections early in life (Jackson et al., 2008,
2012). In those genetically at risk of asthma, rhinovirus-induced
wheezing in the first 3 years of life is the greatest risk factor for
developing asthma at 6 years of age (Jackson et al., 2008). Whether
there is a causal relationship between viruses and asthma devel-
opment or whether infection and asthma have shared risk factors
is not entirely clear, but it has been suggested that the release of
inflammatory products and enhanced viral shedding provide a
strong stimulus for recruitment of immature DCs and their prim-
ing for allergen sensitization (Holgate et al., 2009; Kumar and
Grayson, 2009). It has been demonstrated that absence of NK cells
during primary RSV infection of mice resulted in the suppression
of IFNγ production, as well as the development of an RSV specific
Th2 response leading to an allergic airway response to bystander
antigens (Kaiko et al., 2010). This development of an allergic air-
way response appeared to be due to the loss of IFNγ production
in the absence of NK cells and subsequent increased production
of IL-25 by airway epithelial cells (Kaiko et al., 2010). Thus, NK
cell function may be a major determinant of the development of
viral associated asthma (Figure 1).
Mouse models indicate NK cells may also have an important
role in the allergic airway response beyond a relationship with
viral infection. NK cells have been demonstrated to contribute to
the initiation and development of T-cell mediated allergic airway
inflammation (Korsgren et al., 1999; Wingett and Nielson, 2003;
Ple et al., 2010). NK cell recruitment and accumulation at the site
of immunization and generation of a panel of cytokines which are
involved in the pathogenesis of allergic inflammation suggest that
these cells play a critical role at several steps in the development of
the acquired immune response to allergens. Additionally, NK cells
have been demonstrated to produce IFN-γ, TNF-α, GM-CSF, and
MIP-1α upon IgE stimulation and exhibit cytotoxicity against IgE-
coated target cells in an FcγRIII-dependent manner (Arase et al.,
2003). The fact that NK cells can be activated with IgE through
FcγRIII resulting in cytokine/chemokine production implies that
NK cells may contribute to IgE-mediated allergic responses.
Early clinical observations indicated that NK activity was
enhanced in peripheral blood from asthmatic subjects (Timo-
nen and Stenius-Aarniala, 1985; Jira et al., 1988) but decreased
immediately following antigen challenge (Jira et al., 1988). It has
been suggested that this decrease in NK activity following antigen
challenge reflects migration of NK cells from the circulation to
lymphoid compartments and the lungs (Jira et al., 1988; Culley,
2009). However, it cannot be excluded that agents in the circu-
lation of challenged allergic individuals may directly inhibit NK
activity (Jira et al., 1988). A more recent study (Lin et al., 2003)
demonstrated that NK cell frequency was increased in peripheral
blood from asthmatic children during acute exacerbation when
compared to stable asthmatics. However, during an exacerba-
tion, peripheral blood NK cell expression of adhesion molecules,
ICAM-1 and L-selectin, were significantly decreased. Again, it was
suggested that during an exacerbation of asthma, NK cells express-
ing ICAM-1 and L-selectin may selectively migrate into inflamed
lung tissues or, alternatively, subsets of NK cells that do not express
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FIGURE 1 | Potential role of NK cells in the development of allergic
airway disease. (A) A robust NK cell response to respiratory viral infection
with high levels of IFNγ production and cytolytic activity this leads to viral
clearance and Th1 environment in the lung and normal tolerance to
environmental antigens. (B) An impaired response to viral infection with
low IFNγ and cytolytic activity and higher levels of Th2-type cytokines
released from NK cells leads to increased inflammation and viral shedding,
the recruitment of immature DCs, allergic sensitization with subsequent
inflammation.
ICAM-1/L-selectin are expanded. Clearly, further clinical studies
are required to characterize the phenotype and function of NK
cells in allergic individuals and directly address the fate of the cells
following antigen challenge of the airway.
With regard to animal models, Ple et al. (2010) demonstrated
that sensitization and airway challenge with OVA increased the
number of immature CD27lowCD11blow and CD27highCD11blow
NK cells in the draining lymph nodes of the mouse lung. The NK
cells in the lung lymph nodes expressed higher levels of CD86,
suggesting that cross-talk between these cells and CD4+ T-cells
may be important, potentially increasing Th2 cytokine produc-
tion. Depletion of NK cells following OVA challenge lead to a
dramatic decrease in eosinophil influx to the airway in response
to antigen challenge (Ple et al., 2010). In contrast, a previous study
demonstrated that eosinophilic airway inflammation was reduced
when NK cells were depleted prior to sensitization, while deple-
tion following sensitization, just prior to antigen challenge, had no
significant effect (Korsgren et al., 1999). Similarly, depletion of NK
cells prior to sensitization lead to a decrease in serum IgE while
depletion following sensitization did not alter IgE levels (Korsgren
et al., 1999). The reasons for the differences between studies in
relation to the effect of depleting NK cells following the sensitiza-
tion phase are unclear. However, it is suggested that NK cells may
influence multiple pathways during the progression of asthma. NK
cells may be involved in the development of a Th2 response but do
not appear to influence this response once it is established and may
instead be involved in recruiting eosinophils through the release
of IL-5. An effect that has been described following IgE-mediated
activation of NK cells (Arase et al., 2003).
While there is good evidence for a pro-inflammatory and
asthma-promoting role of NK cells, there are also indications that
these cells are involved in the resolution of acute allergic airway
inflammation. Haworth et al. (2011) demonstrated that during
clearance of eosinophils and T-cells from the airway following
an inflammatory response there are increased numbers of acti-
vated NK cells. Depletion of NK cells delayed the resolution of
both eosinophils and CD4+ T-cells from the lungs. Furthermore,
neutralizing CXCR3 on NK cells impeded the NK cells’ ability to
reach lung lymph nodes and also delayed resolution (Haworth
et al., 2011) of inflammation.
With existing evidence suggesting that NK cells are involved in
both the promotion and inhibition of allergic lung inflammation,
it will be important to determine the mechanisms underlying these
contrasting roles and to determine how the shift in cell function,
from promoting to resolving inflammation, occurs.
NK SUBTYPES AND ASTHMA
In addition to the rapid production of IFN-γ, NK cells have the
potential to generate a range of other cytokines, including IL-5,
IL-8, IL-10, IL-22, IFN-γ, TNF, GM-CSF, MCP-1, MIP-1α, and
RANTES (Michel et al., 2010). Indeed, based on the profile of
cytokine production, NK cells can be divided into different func-
tional subsets, analogous to T-cell subsets (Th1/Th17, Th2, and T
regulatory cells). Thus, NK1/NK17 cells produce IFN-γ and IL-17
(Pandya et al., 2011), whereas NK2 cells produce IL-4, IL-5, and
IL-13 (Loza and Perussia, 2001; Katsumoto et al., 2004), and NKreg
secrete TGFβ and IL-10 (Lang et al., 2012). It has been observed
that NK cells grown in IL-12 produce IL-10 and IFN-γ and express
high levels of Fas, whereas NK cells grown in IL-4 are IL-5-/IL-
13-producing cells, which express low levels of Fas (Peritt et al.,
1998). Additionally, phenotypic and functional characterization of
the NK1 and NK2 cell subsets revealed that human NK2 cells are
CD56lowCCR7−, whereas human NK1 cells are CD56hiCCR7+.
The addition of Cho-kyung-jong-ok-tang (CKJOT), a traditional
Korean herbal formula, to NK cell differentiation cultures sup-
pressed the production of IFN-γ and down-regulated T-bet tran-
scription in NK1 subset, while enhancing the release of IL-5 and
up-regulating Th2 linked transcription factors STAT6 and GATA3
in NK2 subset (Lee et al., 2011). Although most evidence suggests
that NK2 cells arise from NK1 cells, the possibility of both cells
originating from a common precursor (an immature NK cell) has
been suggested (Herberman et al., 1975).
In vivo, microenvironmental factors can condition the genera-
tion and function of distinct NK cell subsets (Di Santo, 2008). Wei
et al. (2005) identified that IL-4+ NK cell frequency was increased
and IFN-γ+ NK cell frequency was decreased in patients with
asthma compared to healthy individuals. Furthermore, success-
ful treatment of the asthmatics leading to reduced symptoms was
associated with a reversal of the shift toward IL-4 expressing NK
cells. Such observations lead the authors to suggest that an NK2
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cell subset is involved in the pathogenesis of asthma. Similarly,
Aktas et al. (2005) demonstrated that NK cells from atopic patients
spontaneously released higher amounts of IL-4, IL-5, IL-13, and
IFN-γ compared to healthy donors. Furthermore, stimulation of
NK cells from allergic individuals, but not control subjects, lead to
a significant increase in IL-5- and IL-13-producing subsets, again
suggesting that NK2 cells are involved in the unbalanced cytokine
profile of allergic inflammation. More recently, it was observed that
the CD56high NK subset is decreased in asthmatic patients (Scor-
damaglia et al., 2008). Furthermore, asthmatics exhibited reduced
NK cell-mediated IFN-γ production in response to DC together
with decreased capability of promoting DC maturation and/or
killing immature DC (Scordamaglia et al., 2008). These findings
suggest that, in addition to enhanced NK2 cell frequency, allergic
asthma is associated with a decreased capability of NK cells to
promote and sustain Th1 responses. The association of NK2 bias
with asthma exacerbation might indicate that immunologic inter-
ventions preventing such an NK bias might benefit patients with
asthma (Ozdemir, 2005). Additionally, given the ability of NK cells
to influence adaptive immune responses, the differential develop-
ment of distinct NK phenotypes in asthma may be an important
influence in disease pathogenesis.
NK CELL INTERACTIONS WITH OTHER IMMUNE CELLS
The regulation of NK phenotype in the normal and asthmatic
lungs will depend on the microenvironment and interactions
with other cell types. Indeed, survival of NK cells within the
airway mucosa may depend on lung epithelial cell-derived IL-15
(Ge et al., 2004). Dendritic cells and macrophages (Laskin et al.,
2001) are among lung resident cells that form synapses (Nedvetzki
et al., 2007; Wehner et al., 2011) with NK cells. Such interac-
tions lead to increased generation of NK-derived cytokines and
effector molecules that are involved in pulmonary immunity and
have the potential to influence allergic disease severity. Resting
NK cells respond rapidly to cytokine signals that are delivered by
myeloid cells (Chenoweth et al., 2012). DC-derived type I inter-
feron (Strowig et al., 2008), IL-12 (Watford et al., 2003), and IL-15
(Lucas et al., 2007) can activate NK cells, leading to secretion of
granular contents and IFN-γ (Gill et al., 2009). DC can attract
NK cells via CCR5 (Van Elssen et al., 2010) or CXCR3 (Pers-
son and Chambers, 2010) and prime the cells to exhibit higher
cytotoxicity and IFNγ production in response to inflammatory
or infectious stimuli (Walzer and Vivier, 2011). IFNγ production
from NK cells can, in turn, polarize CD4+ T-cells toward a Th1
response (Morandi et al., 2006). Conversely, NK cells can attract
immature DCs to lymph nodes, likely through the production
of chemokines such as CXCL1, CCL3, CCL4, and CCL5 (Eber-
lein et al., 2010; Walzer and Vivier, 2011). NK cells activated with
IL-12 can kill immature DCs while NK cells activated with IL-4
do not perform this function (Voehringer et al., 2002). In addi-
tion to interactions with antigen presenting cells, activated T-cells
induce secretion of IFN-γ from human NK cells, an effect medi-
ated by the action of IL-2 on high-affinity receptors constitutively
expressed on the CD56high NK subset (Fehniger et al., 2003). Con-
versely, NK cell activity can be suppressed by TGF-β derived from
CD4+CD25+ regulatory T-cells (Barao et al., 2006). Mast cells
can also modulate NK cell activity. Lipopolysaccharide activated
mast cells can significantly enhance IFN-γ production through a
cell contact dependent mechanism that depends, in part, on OX40
ligand expressed by the mast cell (Vosskuhl et al., 2010).
It appears that the cytokine profile and cellular makeup of the
microenvironment leads to the development of specific NK sub-
types. Similarly, particular combinations of chemokines attract
selected NK subtypes to sites of inflammation. As cellular cytokine
and chemokine profiles do change over the course of an inflam-
matory response, this may lead to the sequential transformation
of NK cells from a pro-inflammatory to a pro-resolution subtype
(Walzer and Vivier, 2011). In the case of asthma, defects or dis-
ruption of this process could lead to prolonged and more severe
inflammation leading to airway damage.
THE THERAPEUTIC POTENTIAL OF NK CELLS IN ASTHMA
Evidence indicates that NK cells have a disease-promoting or
disease-controlling role in allergic asthma via their contribution
to allergen-specific immune suppression, allergen-specific Th1 cell
generation, and IgE production (Erten et al., 2008). Thus, ongo-
ing studies should focus on NK cell subsets and their interactions
with other immune cells during sensitization and the inflamma-
tory response to antigen challenge in lung mucosa. Such studies
will provide powerful insights into the therapeutic potential of NK
cells.
In the past decade, the adoptive transfer of in vitro-cultured
and -activated human NK cells has been applied toward the treat-
ment of certain cancers (Gill et al., 2009). Although such adoptive
transfers are generally thought to be transient due to a relatively
short lifespan of NK cells, Sun et al. (2009) demonstrated that after
mouse Cytomegalovirus infection, long-lived NK cells are gener-
ated and exist for months in lymphoid and non-lymphoid tissue
sites. These long-lasting NK cells can mount protective secondary
responses when the virus is reencountered (Sun et al., 2009). More
recently, the same researchers demonstrated that adoptive transfer
of mature NK cells into lymphopenic mice resulted in the gen-
eration of a long-lived cell population (Sun et al., 2011). Such
homeostasis-driven NK cells maintained activity in the recipient
for longer than 6 months. These findings have led to suggestions
that methods may be developed, which allow for the adoptive
transfer of long-lasting and/or self-renewing NK cells that persist
for months to years and may provide potent therapeutic strategies
for cancers or viral infection (Sun and Lanier, 2011; Sun et al.,
2011). However, the potential detrimental effects of having a per-
sistent population of activated NK cells, for example, the risk of
graft versus host disease, remain to be explored.
It may be possible that a similar adoptive transfer approach
could be extended toward asthma therapy. In vitro expansion and
adoptive transfer of a desired subset of NK cells, or endogenous
expansion of NK cells in vivo with the use of appropriate cytokines,
could represent therapeutic approaches to resolve allergic inflam-
mation. Options could include inducing NKreg mediated sup-
pression or enhancing NK1 cells to balance the skew toward type
2 immune responses in allergic asthma. However, the ability to
maintain the transferred cells phenotype in the face of the cytokine
milieu and cellular microenvironment of the recipient is uncertain.
Another, perhaps more readily achievable, approach to mod-
ulating NK phenotype and function could be to take advantage
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of the cell response to commensal microbes. In mouse studies,
administration of certain lactic acid bacteria (LAB) can protect
against respiratory pathogens (Hori et al., 2002; Yasui et al., 2004;
Harata et al., 2010; Izumo et al., 2010; Kawashima et al., 2011;
Kawase et al., 2012). These protective effects do not require direct
exposure of the organism to the airway mucosa. LAB can atten-
uate airway infection through an interaction with the gut associ-
ated lymphoid tissue, such as Peyer’s patches, leading to indirect
enhancement of respiratory immunity. In a number of studies the
protective effects of both intranasal and oral bacteria have been
associated with up-regulation of NK cell activity in the airway
mucosa (Yasui et al., 2004; Harata et al., 2010; Izumo et al., 2010;
Kawase et al., 2012). A recent study demonstrated that oral admin-
istration of Lactobacillus plantarum significantly reduced lung
viral titer in a mouse model of influenza infection. The reduced
viral titer was associated with increases in pulmonary IFN-α, IL-12,
and IFN-γ production and a marked up-regulation of splenic NK
activity (Takeda et al., 2011). The increases in pulmonary IFN-γ
and IL-12 production also correlated with augmentation of IFN-γ
and IL-12 receptor mRNA expression in Peyer’s patches, suggesting
that the bacteria can elicit immunomodulatory effects in the lung
by stimulating intestinal immunity. Koizumi et al. (2008) demon-
strated that feeding mice with L. pentosus significantly enhanced
NK activity of spleen cells and induced NK1.1-positive NK and
NK T-cells to produce IFN-γ. The increase in IFN-γ production
did not occur through direct action of L. pentosus on NK cells
but was dependent on IL-12 produced by CD11c+ DCs following
a toll-like receptor (TLR) 2- and/or TLR4-dependent interaction
between the DC and the bacteria. Strains of LAB differ greatly in
their ability to induce high levels of IL-12 in human DCs and con-
sequently DC-dependent IFN-γ production by NK cells (Koizumi
et al., 2008). LAB treatment has also been demonstrated to atten-
uate allergic responses, repressing IgE production and reducing
antigen-induced inflammation (Shida et al., 2002; Fujiwara et al.,
2004; Forsythe et al., 2007). There is good evidence that the anti-
allergy effects of certain LAB strains is associated with the ability
of the bacteria to skew the allergic Th2 response toward a Th1
response via the induction of IL-12 in antigen presenting cells
(Shida et al., 1998, 2002; Fujiwara et al., 2004; Pohjavuori et al.,
2004; Ongol et al., 2008; Izumo et al., 2010; Kawashima et al.,
2011). Given the role of NK cells in establishing a Th1 response, it
is tempting to suggest that NK cell-derived IFN-γ released follow-
ing interaction with DC contributes to the Th1 polarizing effects
of certain LAB. Thus, investigation of how specific bacterial sig-
nals differentially regulate the development of NK subtypes may
aid in the development of microbial-based therapeutic strategies
for lung infections and inflammatory diseases, including asthma.
CONCLUSION
A better understanding of the mechanisms of action of NK cells
in allergic asthma is needed. NK cells appear to contribute to
the sensitization phase of an allergen-specific adaptive immune
response, to the balance between a Th1 and Th2-type response
and also to the resolution of ongoing inflammation. The influ-
ence of NK cells on these processes is dependent on the activation
state and subtype of the cells that, in turn, is strongly dependent
on elements on the lung microenvironment, including commen-
sal organisms, pathogens, and the inflammatory state. Increased
evidence of cross-talk between NK cells and other immune cells
has raised the possibilities of exploiting this interplay to regu-
late activation and inhibition of NK cells for immunotherapeutic
purposes. Thus, through secretion of cytokines such as IFN-γ or
IL-5, NK cells could influence antigen presenting cells, DC mat-
uration, and the eosinophil influx that is associated with allergic
airway disease. Cytolytic mechanisms may also contribute to the
influence of NK cells in allergic airway disease, with lysis of DCs
or macrophages modulating antigen presentation and, in turn,
influencing the T-cell response. Questions that remain include:
how do various subtypes of NK cells and specific NK-derived
cytokines/chemokines contribute to the promotion/cessation of
allergic sensitization? What governs the polarization of NK sub-
types during the progression of inflammation? and to what
degree does disruption of this process contribute to asthma
pathogenesis?
With increased knowledge, it may be possible to direct the
recruitment and development of specific subtypes of NK cells
that will provide protective and/or therapeutic strategies in allergic
airway disease.
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